The IVNS1ABP Knockout HT29 Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the IVNS1ABP gene in the HT29 colorectal adenocarcinoma cell line. This loss-of-function model enables systematic investigation of IVNS1ABP-dependent cellular processes without the isolation of single-cell clones, preserving the heterogeneous genetic background of the parental line while achieving targeted gene disruption across the population.
The HT29 host cell line is derived from a human colorectal adenocarcinoma and serves as a well-established model for intestinal epithelial barrier function and differentiation. These epithelial cells are widely employed in studies of colorectal cancer biology, drug absorption profiling, and the molecular mechanisms governing intestinal epithelial homeostasis. Their capacity to form polarized monolayers and undergo mucinous differentiation under appropriate culture conditions makes them particularly relevant for investigating pathways that influence epithelial integrity and oncogenic transformation.
IVNS1ABP encodes a multi-functional protein that mediates pre-mRNA splicing regulation, mRNA export, cellular stress responses, antiviral innate immunity, cell cycle control, and apoptosis. It directly interacts with influenza virus NS1 to antagonize viral replication by preventing NS1-mediated inhibition of host defenses. In the mRNA processing machinery, IVNS1ABP associates with spliceosomal factors such as U2AF and SR proteins, and with the TREX complex components THO and ALYREF, facilitating transcript maturation and export. Stress stimuli recruit IVNS1ABP to stress granules containing TIA-1 and G3BP1. The protein is regulated by interferon signaling, NS1, heat shock, oxidative stress, and ARS2; it influences downstream splicing of interferon-?? mRNA and modulates Bcl-2 family apoptosis regulators, while also intersecting with NF-??B signaling.
In HT29 colorectal adenocarcinoma cells, disrupting IVNS1ABP provides insight into its role in intestinal epithelial differentiation and tumorigenesis. The model is ideal for studying host-virus interactions at the mucosal barrier, particularly influenza virus infection, given the direct binding of NS1. The polyclonal knockout format mimics the heterogeneity of patient tumors, strengthening translational relevance.
Researchers can apply this polyclonal knockout system in colorectal cancer studies using proliferation and apoptosis assays, splicing analyses via RNA-seq, and immunoprecipitation of spliceosomal components. Antiviral drug screening against NS1?CIVNS1ABP binding can be performed in influenza-infected cultures. Standard techniques like western blotting, RT-qPCR, and immunofluorescence enable efficient validation. For technical support, please contact Ascent Research.
